Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
23
pubmed:dateCreated
2008-12-2
pubmed:abstractText
Significant efforts are being devoted toward the development of effective therapeutic vaccines against cancer. Specifically, well-characterized subunit vaccines, which are designed to generate antitumor cytotoxic CD8 T-cell responses. Because CD4 T cells participate at various stages of CD8 T-cell responses, it is important to study the role of CD4 T cells in the induction and persistence of antitumor CD8 T-cell responses by these vaccines. Recent evidence points to the requirement of CD4 T cells for the long-term persistence of memory CD8 T cells, which in the case of cancer immunotherapy would be critical for the prevention of tumor recurrences. The purpose of the present study was to assess whether CD4 T cells are necessary for the generation and maintenance of antigen-specific CD8 T cells induced by subunit (peptide or DNA) vaccines. We have used a vaccination strategy that combines synthetic peptides representing CD8 T-cell epitopes, a costimulatory anti-CD40 antibody and a Toll-like receptor agonist (TriVax) to generate large numbers of antigen-specific CD8 T-cell responses. Our results show that the rate of decline (clonal contraction) of the antigen-specific CD8 T cells and their functional state is not affected by the presence or absence of CD4 T cells throughout the immune response generated by TriVax. We believe that these results bear importance for the design of effective vaccination strategies against cancer.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19047170-11895927, http://linkedlifedata.com/resource/pubmed/commentcorrection/19047170-11936929, http://linkedlifedata.com/resource/pubmed/commentcorrection/19047170-12414983, http://linkedlifedata.com/resource/pubmed/commentcorrection/19047170-12594515, http://linkedlifedata.com/resource/pubmed/commentcorrection/19047170-12690202, http://linkedlifedata.com/resource/pubmed/commentcorrection/19047170-1322235, http://linkedlifedata.com/resource/pubmed/commentcorrection/19047170-14971034, http://linkedlifedata.com/resource/pubmed/commentcorrection/19047170-15007094, http://linkedlifedata.com/resource/pubmed/commentcorrection/19047170-15240684, http://linkedlifedata.com/resource/pubmed/commentcorrection/19047170-15300249, http://linkedlifedata.com/resource/pubmed/commentcorrection/19047170-15454922, http://linkedlifedata.com/resource/pubmed/commentcorrection/19047170-15662368, http://linkedlifedata.com/resource/pubmed/commentcorrection/19047170-15744305, http://linkedlifedata.com/resource/pubmed/commentcorrection/19047170-15922965, http://linkedlifedata.com/resource/pubmed/commentcorrection/19047170-16455988, http://linkedlifedata.com/resource/pubmed/commentcorrection/19047170-16824119, http://linkedlifedata.com/resource/pubmed/commentcorrection/19047170-16920921, http://linkedlifedata.com/resource/pubmed/commentcorrection/19047170-17283170, http://linkedlifedata.com/resource/pubmed/commentcorrection/19047170-17339421, http://linkedlifedata.com/resource/pubmed/commentcorrection/19047170-18056368, http://linkedlifedata.com/resource/pubmed/commentcorrection/19047170-18253731, http://linkedlifedata.com/resource/pubmed/commentcorrection/19047170-18363998, http://linkedlifedata.com/resource/pubmed/commentcorrection/19047170-9346850, http://linkedlifedata.com/resource/pubmed/commentcorrection/19047170-9624003, http://linkedlifedata.com/resource/pubmed/commentcorrection/19047170-9624004, http://linkedlifedata.com/resource/pubmed/commentcorrection/19047170-9624005, http://linkedlifedata.com/resource/pubmed/commentcorrection/19047170-9687535
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1538-7445
pubmed:author
pubmed:issnType
Electronic
pubmed:day
1
pubmed:volume
68
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
9892-9
pubmed:dateRevised
2011-6-7
pubmed:meshHeading
pubmed-meshheading:19047170-Animals, pubmed-meshheading:19047170-Antigens, CD40, pubmed-meshheading:19047170-CD4-Positive T-Lymphocytes, pubmed-meshheading:19047170-CD8-Positive T-Lymphocytes, pubmed-meshheading:19047170-Cancer Vaccines, pubmed-meshheading:19047170-Epitopes, T-Lymphocyte, pubmed-meshheading:19047170-Female, pubmed-meshheading:19047170-Histocompatibility Antigens Class II, pubmed-meshheading:19047170-Lymphoma, B-Cell, pubmed-meshheading:19047170-Mammary Neoplasms, Experimental, pubmed-meshheading:19047170-Melanoma, Experimental, pubmed-meshheading:19047170-Mice, pubmed-meshheading:19047170-Mice, Inbred BALB C, pubmed-meshheading:19047170-Mice, Inbred C57BL, pubmed-meshheading:19047170-Mice, Knockout, pubmed-meshheading:19047170-Neoplasms, Experimental, pubmed-meshheading:19047170-Toll-Like Receptors, pubmed-meshheading:19047170-Vaccines, DNA, pubmed-meshheading:19047170-Vaccines, Subunit
pubmed:year
2008
pubmed:articleTitle
In vivo expansion, persistence, and function of peptide vaccine-induced CD8 T cells occur independently of CD4 T cells.
pubmed:affiliation
Department of Immunology, Moffitt Cancer Center, Tampa, Florida 33612, USA.
pubmed:publicationType
Journal Article, Research Support, N.I.H., Extramural